Group One Trading’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,600
Closed -$72K 5712
2019
Q1
$72K Sell
15,600
-3,000
-16% -$14.2K ﹤0.01% 3388
2018
Q4
$65K Sell
18,600
-55,300
-75% -$384K ﹤0.01% 3413
2018
Q3
$745K Sell
73,900
-60,600
-45% -$483K 0.01% 1939
2018
Q2
$974K Sell
134,500
-80,100
-37% -$559K 0.01% 1751
2018
Q1
$1.3M Buy
214,600
+42,000
+24% +$347K 0.01% 1313
2017
Q4
$1.66M Buy
172,600
+145,800
+544% +$954K 0.01% 1319
2017
Q3
$238K Sell
26,800
-52,700
-66% -$544K ﹤0.01% 2644
2017
Q2
$1.01M Sell
79,500
-28,700
-27% -$340K 0.01% 1447
2017
Q1
$1.14M Sell
108,200
-12,500
-10% -$133K 0.01% 1261
2016
Q4
$1.11M Buy
120,700
+100,300
+492% +$1.13M 0.01% 1253
2016
Q3
$241K Buy
20,400
+11,400
+127% +$173K ﹤0.01% 2333
2016
Q2
$116K Sell
9,000
-44,600
-83% -$650K ﹤0.01% 2763
2016
Q1
$857K Sell
53,600
-77,100
-59% -$1.46M 0.01% 1292
2015
Q4
$3.74M Buy
130,700
+74,200
+131% +$2.06M 0.04% 500
2015
Q3
$1.61M Sell
56,500
-95,200
-63% -$3.5M 0.02% 924
2015
Q2
$5.45M Buy
151,700
+147,300
+3,348% +$4.59M 0.08% 292
2015
Q1
$128K Sell
4,400
-20,000
-82% -$529K ﹤0.01% 2714
2014
Q4
$514K Buy
24,400
+2,000
+9% +$39.5K 0.01% 1540
2014
Q3
$434K Buy
22,400
+8,600
+62% +$135K 0.01% 1725
2014
Q2
$215K Buy
13,800
+13,000
+1,625% +$210K ﹤0.01% 2342
2014
Q1
$17K Buy
+800
New +$15.9K ﹤0.01% 4350

Other funds holding INSY

Group One Trading's INSY Position: Q2 2019 in Review

Group One Trading sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 11,460 shares — an estimated $53K sold.

Group One Trading first reported a position in INSY in Q4 2013 and held it in 7 quarters. The position peaked at $286K in Q1 2016. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Group One Trading reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Group One Trading sold 11,460 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $53K.
  • Group One Trading first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 7 quarters.
  • Group One Trading's Insys Therapeutics, Inc. position peaked at $286K in Q1 2016.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Group One Trading's 13F filing for Q2 2019, filed 9 Aug 2019.